NPC’s comments to the Department of Health and Human Services' Request for Information recommend that the application of anti-kickback statute to value-based contracts should be clarified in a manner that supports the transition to value-based reimbursement.

NPC announced that Richard H. Bagger, Executive Vice President, Corporate Affairs and Market Access, Celgene Corporation, has been elected Chairman of NPC’s Board of Directors for 2018-2019. NPC also elected new members to the Board executive and advisory committees.   

NPC's Dan Leonard explains in Specialty Pharmacy Times how expanding HCEI for sophisticated audiences like payers and population health decision-makers benefits all stakeholders, and underscores the need to resolve remaining reimbursement and regulatory barriers that hinder the development of value-based contracts.